CH BIOTECH SER

08037

0.5652.59% ( -0.015 )

Delay Closed: Oct 5, 16:08:05

Current ValuationThe current P/E ratio is -29.73, below the reasonable range, cheaper than 98.46% of the time in the past 5 years, and the industry ranks 23/31, the industry Median 9.20.

-29.73xP/E

Stock priceHK$0.57Earnings per shareHK$-0.02

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.

Industry median 9.20x

0336699132

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.

Industry median 9.20x

0x40x80x120x160x200x

P/E ratio
Name/Symbol
02522HKRIMAG GROUP	-75.35x	519.00%	HK$2.31B
09960HKKINDSTAR GLOBAL	-19.85x	--	HK$949.30M
09686HKXIKANG CLOUD	-41.43x	--	HK$833.46M
02661HKQINGSONG HEALTH	-1.27x	--	HK$755.67M
08037HKCH BIOTECH SER	-29.73x	--	HK$551.29M
03869HKHOSPITAL CORP	-206.87x	--	HK$467.79M
02389HKBJ HEALTH	-4.22x	--	HK$436.23M
01947HKMEIHAO GROUP	-20.30x	--	HK$321.08M
00286HKAIDIGONG	-1.30x	--	HK$251.76M
01406HKCLARITY MEDICAL	-4.13x	--	HK$191.62M
08357HKREPUBLIC HC	-4.59x	--	HK$94.22M
08161HKMEDINET GROUP	-5.90x	--	HK$19.14M
08437HKRMH HOLDINGS	-0.53x	--	HK$16.65M

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.